What's new

[Cyprus Times] Moderna develops updated vaccines against new Omicron subtypes

moderna.jpg

Moderna is developing updated vaccines against new Omicron subvariants

Pharmaceutical and biotechnology company Moderna announced Monday that it is developing two updated vaccines against the Omicron variant of coronavirus[/B] for the fall[/B]: one designed against the BA sub variant.1 and another against subvariants BA.4 and BA.5.

Vaccine manufacturers, including Moderna and Pfizer, are developing updated vaccines against the rapidly spreading subvariants BA.4 and BA.5 of Omicron, which have been spreading in recent weeks in the United States.

The bivalent vaccines are designed to target two different variants the original one from 2020 and the newer ones brought on by Omicron.

According to Moderna, new clinical data for its mRNA-1273.214 vaccine developing against variant BA.1, showed significantly higher neutralizing antibody responses against rapidly spreading BA.4 and BA.5 compared to current booster doses.

The company's second vaccine, mRNA-1273.222, targets BA.4/5 strains and is being developed in accordance with recent US Food and Drug Administration (FDA) recommendations.

Source: Cyprus Times


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top